MATTHEW R PETERSON
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- Uvalde, TX
- NPI
- 1730475351
- Received
- $4,279 in 205 records, 2019 to 2025
- As principal investigator
- $121,352 of research payments to others in 20 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 80 | $1,571 |
| 2024 | General payment | 86 | $1,822 |
| 2023 | General payment | 37 | $836 |
| 2021 | General payment | 1 | $19 |
| 2019 | General payment | 1 | $29 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 204 | $4,180 |
| Education | 1 | $99 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | TAIHO ONCOLOGY, INC. | $14 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-12-15 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-12-10 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-12-09 | Caris MPI, Inc. | $13 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-12-04 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-12-02 | Gilead Sciences, Inc. | $26 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-11-18 | Karyopharm Therapeutics Inc. | $18 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-11-11 | GENZYME CORPORATION | $16 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-11-10 | Janssen Biotech, Inc. | $25 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-11-02 | AstraZeneca Pharmaceuticals LP | $27 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-10-21 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-10-16 | Incyte Corporation | $16 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-10-15 | Agios Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2025 | |
| 2025-10-14 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-10-02 | Bayer Healthcare Pharmaceuticals Inc. | $30 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-09-30 | SHIELD THERAPEUTICS INC | $17 | Food and Beverage | In-kind items and services | ACCRUFER Drug, Hematology | 2025 | |
| 2025-09-23 | Janssen Biotech, Inc. | $25 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-09-18 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-17 | Geron Corporation | $21 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-09-06 | pharmaand GmbH | $12 | Food and Beverage | In-kind items and services | Rubraca Drug, PARP inhibitor | 2025 | |
| 2025-09-02 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-08-28 | Caris MPI, Inc. | $13 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-08-26 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-08-26 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-08-25 | SOBI, INC | $19 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-08-21 | Incyte Corporation | $13 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-08-19 | Sumitomo Pharma America, Inc. | $28 | Food and Beverage | In-kind items and services | ORGOVYX Drug, PROSTATE CANCER | 2025 | |
| 2025-08-12 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-08-06 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-08-05 | Incyte Corporation | $25 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-07-30 | Bayer Healthcare Pharmaceuticals Inc. | $29 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2025 | |
| 2025-07-14 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | TIVDAK Biological, ONCOLOGY | 2025 | |
| 2025-07-09 | Aveo Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-07-07 | Celgene Corporation | $22 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-07-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage (3 payments) | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-07-02 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-06-24 | Astellas Pharma US Inc | $25 | Food and Beverage | In-kind items and services | Xospata Drug, Oncology | 2025 | |
| 2025-06-24 | Caris MPI, Inc. | $16 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-06-16 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-06-12 | Gilead Sciences, Inc. | $26 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-05-28 | RECORDATI_RARE_DISEASES_INC. | $21 | Food and Beverage | In-kind items and services | SYLVANT Drug, ONCOLOGIC AGENT | 2025 | |
| 2025-05-28 | Kerecis Limited | $2 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-05-27 | Kerecis Limited | $16 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-05-22 | GENZYME CORPORATION | $28 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-05-14 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2025 | |
| 2025-05-14 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | TIVDAK Biological, ONCOLOGY | 2025 | |
| 2025-05-09 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-05-08 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-05-06 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-04-29 | ARRAY BIOPHARMA INC | $24 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-04-24 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-04-17 | Karyopharm Therapeutics Inc. | $15 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-04-16 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-04-10 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-04-09 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-04-08 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-04-02 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-03-27 | Regeneron Healthcare Solutions, Inc. | $23 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-03-20 | TOLMAR, INC. | $17 | Food and Beverage | In-kind items and services | RUBRACA Drug, Prostate Cancer | 2025 | |
| 2025-03-20 | pharmaand GmbH | $17 | Food and Beverage | In-kind items and services | Rubraca Drug, PARP inhibitor | 2025 | |
| 2025-03-18 | Astellas Pharma US Inc | $13 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-03-06 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-03-04 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-03-03 | Geron Corporation | $14 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-02-27 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-02-27 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-24 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-02-20 | JAZZ PHARMACEUTICALS INC. | $15 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-02-19 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-02-18 | Incyte Corporation | $14 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-02-17 | Karyopharm Therapeutics Inc. | $15 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-02-13 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-02-13 | SHIELD THERAPEUTICS INC | $19 | Food and Beverage | In-kind items and services | ACCRUFER Drug, Hematology | 2025 | |
| 2025-02-05 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-01-15 | ARRAY BIOPHARMA INC | $21 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-01-15 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-01-13 | TOLMAR, INC. | $15 | Food and Beverage | In-kind items and services | RUBRACA Drug, Prostate Cancer | 2025 | |
| 2025-01-13 | pharmaand GmbH | $15 | Food and Beverage | In-kind items and services | Rubraca Drug, PARP inhibitor | 2025 | |
| 2025-01-10 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | TIVDAK Biological, ONCOLOGY | 2025 | |
| 2025-01-08 | GENZYME CORPORATION | $21 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2024-12-17 | RECORDATI_RARE_DISEASES_INC. | $14 | Food and Beverage | In-kind items and services | SYLVANT Drug, ONCOLOGIC AGENT | 2024 | |
| 2024-12-12 | Geron Corporation | $26 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2024 | |
| 2024-12-10 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2024 | |
| 2024-12-09 | AstraZeneca Pharmaceuticals LP | $10 | Food and Beverage (2 payments) | In-kind items and services | LYNPARZA Drug, Oncology | 2024 | |
| 2024-12-04 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-12-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-25 | ARRAY BIOPHARMA INC | $18 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2024 | |
| 2024-11-21 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-11-13 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-11-13 | Janssen Biotech, Inc. | $1 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-11-12 | Blueprint Medicines Corporation | $18 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2024 | |
| 2024-11-11 | Celgene Corporation | $24 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-11-07 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-10-31 | Astellas Pharma US Inc | $21 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2024 | |
| 2024-10-30 | Daiichi Sankyo Inc. | $16 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-10-29 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-16 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2024 | |
| 2024-10-07 | Incyte Corporation | $20 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-10-01 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-01 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-09-25 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2024 | |
| 2024-09-25 | Blueprint Medicines Corporation | $17 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2024 | |
| 2024-09-19 | Karyopharm Therapeutics Inc. | $20 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2024 | |
| 2024-09-12 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-09-04 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-09-03 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-08-30 | Daiichi Sankyo Inc. | $25 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2024 | |
| 2024-08-22 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-14 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2024 | |
| 2024-08-13 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2024 | |
| 2024-08-13 | Daiichi Sankyo Inc. | $13 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2024 | |
| 2024-08-07 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-08-06 | Incyte Corporation | $20 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-08-03 | Regeneron Healthcare Solutions, Inc. | $32 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-07-17 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-07-11 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-07-10 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2024 | |
| 2024-07-08 | Janssen Biotech, Inc. | $99 | Education | In-kind items and services | DARZALEX Biological, Oncology | 2024 | |
| 2024-07-03 | PUMA BIOTECHNOLOGY, INC. | $21 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-27 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-06-20 | Bayer Healthcare Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2024 | |
| 2024-06-13 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-06-10 | JAZZ PHARMACEUTICALS INC. | $15 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-06-05 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-30 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2024 | |
| 2024-05-28 | Stemline Therapeutics Inc. | $22 | Food and Beverage | In-kind items and services | ELZONRIS Drug, Oncology | 2024 | |
| 2024-05-21 | Astellas Pharma US Inc | $27 | Food and Beverage | In-kind items and services | Xospata Drug, Oncology | 2024 | |
| 2024-05-21 | RECORDATI_RARE_DISEASES_INC. | $15 | Food and Beverage | In-kind items and services | SYLVANT Drug, ONCOLOGIC AGENT | 2024 | |
| 2024-05-16 | SOBI, INC | $14 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-05-15 | JAZZ PHARMACEUTICALS INC. | $21 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-05-14 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2024 | |
| 2024-05-09 | Novartis Pharmaceuticals Corporation | $5 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-05-08 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2024 | |
| 2024-05-07 | Incyte Corporation | $21 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-05-03 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-01 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2024 | |
| 2024-04-18 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-04-16 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-04-15 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-04-11 | PFIZER INC. | $71 | Food and Beverage | In-kind items and services | TIVDAK Biological, Oncology | 2024 | |
| 2024-04-10 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-03-28 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-27 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-03-25 | Incyte Corporation | $14 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-03-22 | SOBI, INC | $28 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-03-20 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2024 | |
| 2024-03-19 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-03-18 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2024 | |
| 2024-03-07 | Gilead Sciences, Inc. | $26 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-04 | Celgene Corporation | $22 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-02-21 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-02-14 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-02-12 | Bayer Healthcare Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-02-08 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-06 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2024 | |
| 2024-02-01 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-02-01 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2024 | |
| 2024-01-31 | Pharmacosmos Therapeutics Inc. | $22 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2024 | |
| 2024-01-23 | Janssen Biotech, Inc. | $44 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2024 | |
| 2024-01-22 | Astellas Pharma US Inc | $27 | Food and Beverage | In-kind items and services | Xospata Drug, Oncology | 2024 | |
| 2024-01-18 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2024 | |
| 2024-01-11 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-09 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-03 | GENZYME CORPORATION | $14 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-01-02 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | AUGTYRO Drug, Oncology | 2024 | |
| 2023-12-14 | Incyte Corporation | $23 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2023 | |
| 2023-12-13 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2023 | |
| 2023-12-11 | Celgene Corporation | $29 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2023 | |
| 2023-11-29 | PUMA BIOTECHNOLOGY, INC. | $21 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-28 | SOBI, INC | $18 | Food and Beverage | In-kind items and services | Doptelet Drug, HEMATOLOGY/ONCOLOGY | 2023 | |
| 2023-11-27 | Bayer Healthcare Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2023 | |
| 2023-11-02 | ADC THERAPEUTICS AMERICA, INC. | $17 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-02 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2023 | |
| 2023-11-01 | Eisai Inc. | $19 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2023 | |
| 2023-10-05 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2023 | |
| 2023-10-04 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | TASIGNA Drug, Oncology | 2023 | |
| 2023-10-03 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2023 | |
| 2023-09-22 | Pharmacyclics LLC, an AbbVie Company | $14 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2023 | |
| 2023-09-20 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | PIQRAY Drug, Oncology | 2023 | |
| 2023-09-19 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-09-05 | Aveo Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2023 | |
| 2023-08-09 | Janssen Biotech, Inc. | $25 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-08-08 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | PROMACTA Drug, Oncology | 2023 | |
| 2023-07-27 | Gilead Sciences, Inc. | $18 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-07-27 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2023 | |
| 2023-07-25 | Aveo Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2023 | |
| 2023-07-24 | GENZYME CORPORATION | $21 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2023 | |
| 2023-07-12 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-07-10 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-06-01 | SOBI, INC | $16 | Food and Beverage | In-kind items and services | Doptelet Drug, HEMATOLOGY/ONCOLOGY | 2023 | |
| 2023-05-19 | Pharmacosmos Therapeutics Inc. | $21 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2023 | |
| 2023-05-17 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | PROMACTA Drug, Oncology | 2023 | |
| 2023-05-02 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2023 | |
| 2023-04-19 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-04-17 | Bayer Healthcare Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2023 | |
| 2023-04-11 | Stemline Therapeutics Inc. | $20 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2023 | |
| 2023-04-05 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | RETEVMO Drug, Oncology | 2023 | |
| 2023-04-05 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2023 | |
| 2023-03-30 | GENZYME CORPORATION | $16 | Food and Beverage | In-kind items and services | ENJAYMO Biological, Hematology | 2023 |
The latest 200 records of 205.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-03-03 | Regeneron Pharmaceuticals, Inc. | THE GENEVA FOUNDATION | $2,614 | AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBOD | 2022 |
| 2021-12-02 | Janssen Research & Development, LLC | The Geneva Fndtn | $178 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2021-10-14 | Regeneron Pharmaceuticals, Inc. | THE GENEVA FOUNDATION | $12,610 | AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBOD | 2021 |
| 2021-10-14 | Regeneron Pharmaceuticals, Inc. | THE GENEVA FOUNDATION | $950 | AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBOD | 2021 |
| 2021-09-02 | SEAGEN INC. | Brooke Army Medical Center | $3,750 | A Single Cohort Phase 2 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced Stage Hodgkin Lymphoma | 2021 |
| 2021-08-30 | Janssen Research & Development, LLC | The Geneva Fndtn | $536 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2021-08-12 | Janssen Research & Development, LLC | The Geneva Fndtn | $675 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2021-08-11 | SEAGEN INC. | Brooke Army Medical Center | $8,119 | A Single Cohort Phase 2 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced Stage Hodgkin Lymphoma | 2021 |
| 2021-06-09 | SEAGEN INC. | Brooke Army Medical Center | $5,031 | A Single Cohort Phase 2 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced Stage Hodgkin Lymphoma | 2021 |
| 2021-05-17 | Janssen Research & Development, LLC | The Geneva Fndtn | $675 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2021-05-06 | Janssen Research & Development, LLC | The Geneva Fndtn | $12,908 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2021-05-06 | Regeneron Pharmaceuticals, Inc. | THE GENEVA FOUNDATION | $950 | AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBOD | 2021 |
| 2021-04-07 | SEAGEN INC. | Brooke Army Medical Center | $12,747 | A Single Cohort Phase 2 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced Stage Hodgkin Lymphoma | 2021 |
| 2021-03-01 | Janssen Research & Development, LLC | The Geneva Fndtn | $31,882 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in p | 2021 |
| 2020-09-08 | Janssen Research & Development, LLC | The Geneva Fndtn | $4,622 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) | 2020 |
| 2020-09-03 | E.R. Squibb & Sons, L.L.C. | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Incorporated | $4,218 | A Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC: Nivolumab as Maintenance after Induction Chemother | 2020 |
| 2020-05-21 | Janssen Research & Development, LLC | The Geneva Fndtn | $768 | A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) | 2020 |
| 2020-02-25 | E.R. Squibb & Sons, L.L.C. | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Incorporated | $81 | A Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC: Nivolumab as Maintenance after Induction Chemother | 2020 |
| 2019-12-10 | E.R. Squibb & Sons, L.L.C. | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Incorporated | $9,381 | A Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC Nivolumab as Maintenance after Induction Chemothera | 2019 |
| 2019-05-16 | E.R. Squibb & Sons, L.L.C. | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Incorporated | $8,652 | A Master Protocol of Phase II Studies of Nivolumab in Advanced NSCLC Nivolumab as Maintenance after Induction Chemothera | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Uvalde, TX, county Uvalde County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Uvalde, TX | County Uvalde County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 15,417 | 24,881 | 30,188,424 |
| Population, 2020 census P1 | 15,217 | 24,564 | 29,145,505 |
| Median age B01002 | 34.3 | 34.5 | 35.6 |
| Under 18 B01001 | 27.2% | 26.5% | 25.0% |
| 65 and over B01001 | 17.2% | 16.5% | 13.4% |
| Households B11001 | 5,259 | 8,417 | 10,992,816 |
| Foreign born B05002 | 12.1% | 10.9% | 17.6% |
| Median household income B19013 | $51,141 | $53,801 | $78,476 |
| Median family income B19113 | $63,796 | $63,946 | $94,599 |
| Per capita income B19301 | $24,523 | $26,643 | $40,752 |
| Poverty rate B17001 | 23.9% | 22.2% | 13.8% |
| Unemployment rate B23025 | 1.4% | 4.3% | 5.3% |
| Civilian labor force B23025 | 6,438 | 10,727 | 15,233,563 |
| Mean commute (minutes) B08013 | 18.7 | 19.7 | 26.7 |
| Bachelor's degree or higher B15003 | 16.1% | 19.8% | 33.8% |
| Housing units B25001 | 6,061 | 10,095 | 12,128,515 |
| Owner-occupied B25003 | 67.4% | 70.6% | 62.6% |
| Renters B25003 | 32.6% | 29.4% | 37.4% |
| Median home value B25077 | $136,800 | $150,800 | $283,800 |
| Median gross rent B25064 | $994 | $981 | $1,403 |
| White, not Hispanic B03002 | 17.5% | 25.6% | 39.1% |
| Black B03002 | 0.4% | 0.3% | 11.9% |
| Hispanic or Latino B03002 | 78.3% | 70.9% | 39.7% |
| Asian B03002 | 1.5% | 1.1% | 5.5% |
| American Indian and Alaska Native B03002 | 0.5% | 0.3% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Uvalde, TX.
Comments